Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia

Graft Versus Host Disease (GvHD) Market to witness growth by 2034, estimates DelveInsight | ZEMAIRA, EQ001, Jakafi, Temcell, Obnitix, MaaT013, Leukotac, KD025, Itacitinib, more

mountaintoday.in - 20/Jun 06:40

Graft Versus Host Disease (GvHD) Market GvHD companies are Medac, MaaT Pharma, ElsaLys Biotech (Mediolanum Farmaceutici Spa), Syndax Pharmaceutical,...

Survival Improves With Open Hysterectomy for Cervical Cancer

drugs.com - 28/Jun 15:03

FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally...

Immunoglobulin Replacement Therapy Beneficial for Blood Cancers

drugs.com - 27/Jun 15:06

THURSDAY, June 27, 2024 -- Immunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe...

Stem Cells Could Transform Neurological Disease Treatment

medindia.net - 30/Jun 20:48

Stem cell research explores neuron connectivity and communication, paving the way for potential treatments.

Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes

drugs.com - 25/Jun 10:06

TUESDAY, June 25, 2024 -- An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients,...

Endolymphatic Duct Blockage Beneficial for Vertigo in Meniere Disease

drugs.com - 03/Jul 14:07

WEDNESDAY, July 3, 2024 -- Endolymphatic duct blockage (EDB) is more effective than intratympanic methylprednisolone (ITMP) injection for controlling...

ViPOR Results in Durable Remission in Specific Subtypes of Lymphoma

drugs.com - 20/Jun 16:01

THURSDAY, June 20, 2024 -- For patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with...

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia

drugs.com - 24/Jun 23:06

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...

Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer

drugs.com - 01/Jul 15:07

MONDAY, July 1, 2024 -- For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved...

Etiology of Spinal Cord Injury Affects QOL Outcomes After Bladder Surgery